The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
Author(s) -
Po-Kai Yang,
Chih–Yuan Hsu,
MeiJou Chen,
Mei-Yu Lai,
Zheng-Rong Tiger Li,
ChenHsin Chen,
Shee–Uan Chen,
HongNerng Ho
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-01739
Subject(s) - polycystic ovary , medicine , metformin , endocrinology , testosterone (patch) , luteinizing hormone , body mass index , hyperandrogenism , menstrual cycle , overweight , prospective cohort study , hormone , insulin resistance , obesity , insulin
The long-term effects of metformin in women with polycystic ovarian syndrome (PCOS) are inadequately studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom